Brief: Cardiex Subsidiary ATCOR Partners With Invaryant To Enable Clinical Trials
03/01/2023 14:12
Jan 3 (Reuters) - Cardiex Ltd CDX.AX :
* CARDIEX SUBSIDIARY ATCOR PARTNERS WITH INVARYANT TO ENABLE
CLINICAL TRIALS WITH ADVANCED NEW AI MEDICAL TECHNOLOGY
Source text for Eikon: ID:nPnSX1QWa
Further company coverage: CDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Conneqt Health
See all newsAustralia's CONNEQT Health set for biggest weekly gain in 11 months on US distribution deal
Australia's CONNEQT Health extends gains on deal with US-based Blueprint
Australia's Conneqt Health gains most in over 5-months on U.S. distribution deal
Brief: Conneqt Health Enters Commercial Marketing Agreement With Blueprint
Brief: Conneqt Health Posts FY Net Loss Of A$10.86 Million